Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen's Acquisition of Applied Biosystems Clears Antitrust Waiting Period

NEW YORK (GenomeWeb News) - Invitrogen said today that its proposed acquisition of Applied Biosystems has cleared the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976.
 
Invitrogen said it will “soon” begin a similar process with European regulatory authorities.
 
The acquisition is expected to close in late October or early November, subject to approval of both companies' shareholders.
 
Invitrogen said that integration team members from both companies met last week “to discuss proposed milestones and activities for the integration and further review proposed synergies.”
 
Mark Smedley, Invitrogen's global head of operations and leader of the integration team, said in a statement that the companies have “a clear integration model in place and we are well on track to start delivering on the potential of our new company as soon as the transaction closes."

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.